Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.7000
-0.0428 (-5.76%)
At close: Mar 28, 2025, 4:00 PM
0.6603
-0.0397 (-5.67%)
After-hours: Mar 28, 2025, 7:58 PM EDT

Jupiter Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
--0.230.641.13-
Revenue Growth (YoY)
---63.44%-43.35%--
Cost of Revenue
0.540.950.941.451.640.69
Gross Profit
-0.54-0.95-0.71-0.81-0.52-0.69
Selling, General & Admin
1.632.922.723.11.341.49
Operating Expenses
1.632.922.723.11.341.49
Operating Income
-2.17-3.87-3.43-3.91-1.85-2.18
Interest Expense
-0.32-0.22-0.74-0.11-0.01-0.32
Interest & Investment Income
-00000
Other Non Operating Income (Expenses)
0.20.190.26-0.090.280.3
EBT Excluding Unusual Items
-2.29-3.9-3.91-4.11-1.58-2.2
Other Unusual Items
0.95-0.89-1.05-0.09-0.07-0.85
Pretax Income
-1.34-4.78-4.96-4.2-1.65-3.05
Net Income
-1.34-4.78-4.96-4.2-1.65-3.05
Net Income to Common
-1.34-4.78-4.96-4.2-1.65-3.05
Shares Outstanding (Basic)
272625242221
Shares Outstanding (Diluted)
272625242221
Shares Change (YoY)
4.14%3.75%6.69%9.51%5.01%-
EPS (Basic)
-0.05-0.18-0.19-0.18-0.08-0.15
EPS (Diluted)
-0.05-0.18-0.19-0.18-0.08-0.15
Gross Margin
----126.90%-45.74%-
Operating Margin
---1471.38%-612.36%-164.41%-
Profit Margin
---2125.15%-658.31%-146.92%-
EBIT
-2.17-3.87-3.43-3.91-1.85-2.18
EBIT Margin
-----164.41%-
Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q